Mild persistent asthma with (acute) exacerbation
Methodology & AI Transparency ⓘ
Mild persistent asthma with (acute) exacerbation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code J45.31 in Lungs & Asthma, Mild persistent asthma with (acute) exacerbation requires vaccination review [Mild persistent asthma with (acute) exacerbation J45.31] so specialists can calibrate treatment intensity against Blood Eosinophil Count [Mild persistent asthma with (acute) exacerbation J45.31] benchmarks.
- 2 Real-world patient consensus: Clinical coding for Mild persistent asthma with (acute) exacerbation uses ICD-10 J45.31 across Lungs & Asthma specialty care.
- 3 Typical cash cost range: Differential triage of Mild persistent asthma with (acute) exacerbation (J45.31) utilizes vaccination review [Mild persistent asthma with (acute) exacerbation J45.31].
- 4 Top reported side effects / signs: Follow-up benchmark in Mild persistent asthma with (acute) exacerbation: maintaining Blood Eosinophil Count [Mild persistent asthma with (acute) exacerbation J45.31] within < 150 cells/uL (phenotyping marker) (J45.31).
Ask our AI Specialists anything about Mild persistent asthma with (acute) exacerbation
What Is Mild persistent asthma with (acute) exacerbation?
Cataloged under federal diagnostic code J45.31 in Lungs & Asthma, Mild persistent asthma with (acute) exacerbation requires vaccination review [Mild persistent asthma with (acute) exacerbation J45.31] so specialists can calibrate treatment intensity against Blood Eosinophil Count [Mild persistent asthma with (acute) exacerbation J45.31] benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Mild persistent asthma with (acute) exacerbation (J45.31) features alveolar elastic recoil in Mild persistent asthma with (acute) exacerbation (J45.31: loss). therapeutic stabilization in lungs & asthma is verified against Spirometry FEV1 / in Mild persistent asthma with (acute) exacerbation (J45.31: FVC Ratio).
Common Symptoms & Clinical Signs
- • Presentation of Mild persistent asthma with (acute) exacerbation (J45.31): declining stair-climbing stamina in Mild persistent asthma with (acute) exacerbation (J45.31: or frequent rescue)
- • Secondary Mild persistent asthma with (acute) exacerbation clinical sign: episodic wheezing, expiratory in Mild persistent asthma with (acute) exacerbation (J45.31: chest tightness, or)
- • Symptom flares in Mild persistent asthma with (acute) exacerbation correlating with Blood Eosinophil Count [Mild persistent asthma with (acute) exacerbation J45.31] deviation outside < 150 cells/uL (phenotyping marker) (J45.31)
- • Functional lungs & asthma impact requiring vaccination review [Mild persistent asthma with (acute) exacerbation J45.31] evaluation (J45.31)
Mild persistent asthma with (acute) exacerbation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J45.31 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Mild persistent asthma with (acute) exacerbation J45.31] | < 150 cells/uL (phenotyping marker) (J45.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Spirometry FEV1 / in Mild persistent asthma with (acute) exacerbation (J45.31: FVC Ratio) | >= 0.75 (FEV1 >= 80% predicted) (J45.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fractional Exhaled Nitric in Mild persistent asthma with (acute) exacerbation (J45.31: Oxide (FeNO)) | < 25 ppb (J45.31) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Mild persistent asthma with (acute) exacerbation
Treatment selection for Mild persistent asthma with (acute) exacerbation depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mild persistent asthma with (acute) exacerbation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| GLP-1RA vs. Placebo: Which Works Better for Heart failure and mildly reduced or preserved ejection fraction? GLP-1RA reduce HF exacerbations and can play a role in reducing hospitalizations, improving patient's functional status, and significantly impacting the global healthcare burden of HF. International journal of cardiology • 2025-11-01 • Meta-Analysis | N = 4,474 | 99/100 | PMID 40623630 ↗ |
| New Insights on Skin-applied tazarotene in the treatment of mild to moderate: What a 468-Participant Study Found In general, 'using the cream formulation rather than the gel formulation optimized tolerability. Cutis • 2004-10-15 • Meta-Analysis | N = 468 | 97/100 | PMID 15543714 ↗ |
| New Insights on Mineralocorticoid Receptor Antagonism with Finerenone: A New Era in the: What a 13,026-Participant Study Found We explore the emerging role of the nonsteroidal MRA finerenone as a new therapeutic opportunity to improve the risk of adverse heart and blood vessel outcomes in patients with HF and mildly reduced or preserved ejection. American journal of cardiovascular drugs : drugs, devices, and other interventions • 2025-07-15 • Phase III Randomized Trial | N = 13,026 | 96/100 | PMID 40055303 ↗ |
| New Insights on Efficacy of finerenone in patients with heart failure and mildly reduced or: What a 3,497-Participant Study Found Among patients with HFpEF/HFmrEF in FINEARTS-HF, higher baseline HR was associated with a higher risk of the primary outcome in patients with SR but not in those with AF. European journal of heart failure • 2026-05-02 • Phase III Randomized Trial | N = 3,497 | 96/100 | PMID 41771075 ↗ |
| Check Your Medicine Cabinet: Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. c WORCESTER, NY, October 15, 2026 - Family Farmstead Dairy of Worcester, NY is recalling specific lot of cheddar cheese because it may be contaminated with Escherichia coli O157:H7 bacteria (E. Coli O157:H7). E. coli O157:H7 causes a diarrheal illness often with FDA Drug Recalls • 2026-10-15 • FDA Recall | Multi-cohort | 95/100 | PMID FDA_RECALLS-2412744266 ↗ |
Mild persistent asthma with (acute) exacerbation Patient Community & “People Like Me” Threads
Filter Mild persistent asthma with (acute) exacerbation community threads and patient logs by age, biological sex, dosage, and treatment duration.